SteelPeak Wealth’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
Hold
0
-$543K 566
2024
Q2
Hold
0
299
2024
Q1
Hold
0
310
2023
Q1
Hold
0
-$549K 431
2022
Q4
Hold
0
231

Other funds holding LLY

SteelPeak Wealth's LLY Position: Q2 2026 in Review

SteelPeak Wealth increased its Eli Lilly (LLY) stake by 20% in Q2 2026, buying an estimated $893K and bringing the position to 5,219 shares worth $6.26M. The position accounts for 0.16% of the portfolio, ranked #114.

SteelPeak Wealth first reported a position in LLY in Q4 2019 and has held it in 27 quarters since. 2,247 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • SteelPeak Wealth held 5,219 shares of Eli Lilly worth $6.26M as of Q2 2026.
  • SteelPeak Wealth bought 874 Eli Lilly shares in Q2 2026, an estimated $893K.
  • Eli Lilly made up 0.16% of SteelPeak Wealth's portfolio in Q2 2026, its #114 holding.
  • SteelPeak Wealth first reported a position in Eli Lilly in Q4 2019 and has held it in 27 quarters since.
  • 2,247 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on SteelPeak Wealth's 13F filing for Q2 2026, filed 13 Jul 2026.